A therapeutic substitution policy that was expected to save the B.C. government $42 million has instead cost the health care system $43.5 million, says a new study.
Recent media attention has focused on the possibility that long-term proton pump inhibitor (PPI) therapy may lead to an increased risk of hip fracture.
